ArticleFrontiers in immunology2021

Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.

Eliott Lafon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.